Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
153M
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
4.24M
-
Shares change
-
-877K
-
Total reported value, excl. options
-
$34.9M
-
Value change
-
-$13.5M
-
Number of buys
-
23
-
Number of sells
-
-23
-
Price
-
$8.22
Significant Holders of BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) as of Q3 2021
51 filings reported holding BDSX - BIODESIX INC - Common Stock, par value $0.001 per share as of Q3 2021.
BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.24M shares
of 153M outstanding shares and own 2.77% of the company stock.
Largest 10 shareholders include Birchview Capital, LP (1.1M shares), BlackRock Inc. (571K shares), Parian Global Management LP (517K shares), VANGUARD GROUP INC (376K shares), Cannell & Co. (206K shares), ORACLE INVESTMENT MANAGEMENT INC (181K shares), GEODE CAPITAL MANAGEMENT, LLC (151K shares), FRED ALGER MANAGEMENT, LLC (139K shares), STATE STREET CORP (136K shares), and Conestoga Capital Advisors, LLC (115K shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.